Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TREATMENT FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS INDUSTRY
2.1 Summary about Treatment for Syndromes of Dementia and Movement Disorders Industry
2.2 Treatment for Syndromes of Dementia and Movement Disorders Market Trends
2.2.1 Treatment for Syndromes of Dementia and Movement Disorders Production & Consumption Trends
2.2.2 Treatment for Syndromes of Dementia and Movement Disorders Demand Structure Trends
2.3 Treatment for Syndromes of Dementia and Movement Disorders Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Movement Disorders
4.2.2 Progressive Dementia
4.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 ≤70 Years
4.3.2 Above 70 Years
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Movement Disorders
5.2.2 Progressive Dementia
5.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 ≤70 Years
5.3.2 Above 70 Years
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Movement Disorders
6.2.2 Progressive Dementia
6.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 ≤70 Years
6.3.2 Above 70 Years
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Movement Disorders
7.2.2 Progressive Dementia
7.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 ≤70 Years
7.3.2 Above 70 Years
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Movement Disorders
8.2.2 Progressive Dementia
8.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 ≤70 Years
8.3.2 Above 70 Years
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Movement Disorders
9.2.2 Progressive Dementia
9.2.3 Progressive Dementia with Neurological Abnormality (PDNA)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 ≤70 Years
9.3.2 Above 70 Years
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Valeant Pharmaceutical International
10.1.2 AstraZeneca GmbH
10.1.3 F. Hoffmann-La Roche
10.1.4 Abbott Laboratories
10.1.5 Merck
10.1.6 Sanofi
10.1.7 Novartis
10.1.8 Bristol-Myers Squibb
10.1.9 Baxter International
10.1.10 Pfizer
10.2 Treatment for Syndromes of Dementia and Movement Disorders Sales Date of Major Players (2017-2020e)
10.2.1 Valeant Pharmaceutical International
10.2.2 AstraZeneca GmbH
10.2.3 F. Hoffmann-La Roche
10.2.4 Abbott Laboratories
10.2.5 Merck
10.2.6 Sanofi
10.2.7 Novartis
10.2.8 Bristol-Myers Squibb
10.2.9 Baxter International
10.2.10 Pfizer
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type Overview
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type Market Share List
Table Treatment for Syndromes of Dementia and Movement Disorders Product Type of Major Players
Table Brief Introduction of Valeant Pharmaceutical International
Table Brief Introduction of AstraZeneca GmbH
Table Brief Introduction of F. Hoffmann-La Roche
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Merck
Table Brief Introduction of Sanofi
Table Brief Introduction of Novartis
Table Brief Introduction of Bristol-Myers Squibb
Table Brief Introduction of Baxter International
Table Brief Introduction of Pfizer
Table Products & Services of Valeant Pharmaceutical International
Table Products & Services of AstraZeneca GmbH
Table Products & Services of F. Hoffmann-La Roche
Table Products & Services of Abbott Laboratories
Table Products & Services of Merck
Table Products & Services of Sanofi
Table Products & Services of Novartis
Table Products & Services of Bristol-Myers Squibb
Table Products & Services of Baxter International
Table Products & Services of Pfizer
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) by Region 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Forecast (Million USD) Share by Demand 2021f-2026f